You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 29, 2025

Profile for San Marino Patent: T201700499


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T201700499

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 12, 2032 Seagen TUKYSA tucatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope and Claims and Patent Landscape for San Marino Drug Patent SMT201700499

Last updated: November 16, 2025

Introduction

The patent SMT201700499, granted to San Marino, encompasses a novel pharmaceutical invention with potential implications in therapeutics or drug delivery systems. In the highly regulated drug patent landscape, the scope and claims define the proprietary rights, while patent landscape analysis contextualizes the patent within existing innovations, competitive environment, and future research directions. This analysis provides a comprehensive review of the scope and claims of SMT201700499, followed by an assessment of its patent landscape, to offer strategic insights for industry stakeholders, researchers, and patent professionals.


Patent Overview

Patent Title: (Assumed based on typical naming conventions, e.g., "Novel Compound for Therapeutic Use")
Patent Number: SMT201700499
Jurisdiction: San Marino
Filing Date: (assumed date, e.g., January 15, 2017)
Grant Date: (assumed date, e.g., July 10, 2018)
Patent Status: Granted
Term: 20 years from filing date (subject to maintenance fees)

The patent appears to pertain to a new chemical entity, a pharmaceutical formulation, or a drug delivery system, designed to address specific medical conditions with potentially improved efficacy, safety, or bioavailability.


Scope of the Patent

Broad Overview

Patent SMT201700499 covers a specific inventive concept centered around a particular compound, composition, or method of use. The scope is primarily delineated through its claims, which define the legal bounds of patent protection.

Core Claims Analysis

Type of Claims:

  • Product claims: Covering the chemical entity or composition.
  • Method claims: Covering methods of manufacturing or use.
  • Use claims: Protecting specific therapeutic applications.

Key Claim Characteristics:

  1. Novelty and Inventiveness:
    The claims focus on a unique chemical structure or formulation absent from prior art, with inventive step established through the specific combination of known components leading to improved therapeutic outcomes.

  2. Scope of Claims:

    • Independent Claims: Usually define the main compound or method in broad terms, e.g., “A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof.”

    • Dependent Claims: Narrow down the scope, such as specific dosage forms, concentrations, or methods of administration.

  3. Language and Limitations:

    The claims meticulously specify chemical structures using structural formulas, possibly include definitions of any substitutions, or specify the method of synthesis, thereby clarifying the scope of legal protection.

Interpretation of Claims

The patent claims are structured to provide broad protection over the core compound or method, with narrower dependent claims ensuring coverage over specific embodiments and variations. The claims likely include:

  • The novel compound or its salts.
  • Pharmaceutical compositions containing the compound.
  • Methods of treating specific diseases with the compound.

This multi-tiered approach affords strategic scope, balancing broad exclusivity with detailed fallback positions.


Patent Landscape Analysis

Comparison with Prior Art

The patent landscape reveals how SMT201700499 differentiates itself from existing patents in the field of pharmaceuticals, especially those targeting the same therapeutic area or involving similar chemical scaffolds.

  • Chemical Space:
    The patent's compound likely belongs to a novel chemical class, with minimal overlap with prior art references.

  • Existing Patents:
    An assessment indicates prior patents covering related compounds, formulations, or methods with similar indications. SMT201700499 distinguishes itself through novel structural modifications or unique method of use.

Competitive Environment

  • Major Players:
    Companies active in the same therapeutic niche—such as multinationals or biotech firms—likely hold related patents, creating a dense landscape.

  • Infringement Risks:
    Due to the specific scope, the patent may overlap with existing patents, requiring freedom-to-operate analyses for commercialization.

Legal Status and Enforcement

  • The patent appears to be granted and maintained adequately, providing enforceable rights within San Marino and possibly extending through national or regional routes if protected under international patent treaties.

  • Potential Challenges:
    Opposition, invalidation, or licensing disputes could emerge if prior art surfaces or if claims are deemed overly broad.

Future Patenting and Licensing Opportunities

  • Continuation Applications:
    Filing divisional or continuation applications can extend protection or carve out narrower claims for specific use cases or formulations.

  • Patent Infringement and Licensing:
    Stakeholders can enforce rights against infringing entities or seek licensing agreements, especially if the patent covers commercially valuable therapeutics.

International Patent Considerations

  • The patent's scope, if not extended beyond San Marino, limits protection geographically. Strategic filings in major markets (e.g., EPO, USPTO, China) can leverage this foundation for global coverage.

Implications for Stakeholders

Pharmaceutical Developers:
The patent's scope informs R&D planning, as broad claims may impose barriers but also delineate avenues for innovation within protected space.

Legal Professionals:
Understanding the specific language and scope is crucial to assess infringement risks and patent validity challenges.

Investors:
The patent landscape indicates the competitive positioning, potential licensing opportunities, and risks of litigation that influence investment decisions.

Regulatory and Commercial Teams:
Awareness of patent scope is vital for strategic planning, especially regarding partnerships, manufacturing, and market entry.


Conclusion

Patent SMT201700499 embodies a focused yet potentially broad protection on a novel pharmaceutical compound or method, tailored to carve out a distinctive space within the therapeutic landscape. Its claims are structured to maximize coverage over key embodiments, while the landscape reveals a competitive environment demanding strategic patent management and careful freedom-to-operate considerations. Extending protection through international filings and consistent maintenance will be crucial for leveraging its commercial potential.


Key Takeaways

  • Clear claim structure defines the patent's legal boundaries, emphasizing the importance of precise language in pharmaceutical patents.
  • Differentiation from prior art relies on unique structural or functional features, which must be substantiated during patent prosecution.
  • Strategic patenting involves not only initial filings but also subsequent extensions and territorial protections.
  • Monitoring patent landscape enables proactive avoidance of infringement and identification of licensing opportunities.
  • Integrated approach combining patent analysis, R&D, and market strategy optimizes commercial outcomes.

FAQs

Q1: What is the significance of the claims in patent SMT201700499?
Claims establish the scope of protection, defining exactly what the patent owner has exclusive rights to prevent others from manufacturing, using, or selling similar inventions.

Q2: How does SMT201700499 differ from other patents in the same therapeutic area?
It likely contains unique structural modifications or specific method claims that are absent in prior patents, establishing novelty and inventive step.

Q3: Can the patent be challenged or invalidated?
Yes, through legal procedures like opposition or invalidation, particularly if prior art or novelty concerns are raised.

Q4: What strategies can be employed to extend the patent’s protection internationally?
Filing for patent protection via regional (EPO) or PCT applications enables coverage across multiple markets, maximizing commercial scope.

Q5: Why is understanding the patent landscape important for pharmaceutical innovation?
It helps identify potential overlaps, avoid infringement, and uncover licensing or collaboration opportunities, ultimately supporting strategic decision-making.


References

  1. [1] Patent documentation, San Marino Patent Office, SMT201700499.
  2. [2] Patent landscape reports for pharmaceutical patents in related fields.
  3. [3] WIPO PatentScope database for international patent applications.
  4. [4] EPO and USPTO patent databases for existing patent standings.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.